Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CNR2 Antikörper (AA 228-242)

Dieses Anti-CNR2-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von CNR2 in WB und IHC. Geeignet für Ratte.
Produktnummer ABIN7043025

Kurzübersicht für CNR2 Antikörper (AA 228-242) (ABIN7043025)

Target

Alle CNR2 Antikörper anzeigen
CNR2 (Cannabinoid Receptor 2 (CNR2))

Reaktivität

  • 63
  • 27
  • 21
  • 2
  • 1
  • 1
Ratte

Wirt

  • 66
  • 3
  • 1
Kaninchen

Klonalität

  • 67
  • 3
Polyklonal

Konjugat

  • 38
  • 6
  • 5
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CNR2 Antikörper ist unkonjugiert

Applikation

  • 54
  • 32
  • 26
  • 24
  • 13
  • 13
  • 9
  • 8
  • 6
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)
  • Bindungsspezifität

    • 16
    • 12
    • 10
    • 8
    • 5
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 228-242

    Verwendungszweck

    A Rabbit Polyclonal Antibody to Cannabinoid Receptor 2

    Spezifität

    3rd intracellular loop

    Kreuzreaktivität

    Maus, Ratte

    Homologie

    Mouse - identical Human - 14 out of 15 amino acid residues identical

    Produktmerkmale

    Anti-Cannabinoid Receptor 2 Antibody (ABIN7043025, ABIN7044157 and ABIN7044158) is directed against an intracellular epitope of the rat CB2 receptor. Anti-Cannabinoid Receptor 2 Antibody (ABIN7043025, ABIN7044157 and ABIN7044158) can be used in western blot and immunohistochemistry applications, and recognizes CB2 in rat samples.

    Aufreinigung

    Affinity purified on immobilized antigen.

    Immunogen

    Immunogen: Synthetic peptide

    Immunogen Sequence: (C)DRQVPGIARMRLDVR, corresponding to amino acid residues 228-242 of rat CB2 receptor

    Isotyp

    IgG
  • Applikationshinweise

    Antigen preadsorption control: 1 μg peptide per 1 μg antibody

    Application Dilutions Immunohistochemistry paraffin embedded sections ihc: 1:100-1:400

    Application Dilutions Western blot wb: 1:200

    Kommentare

    Cited Application: IHC

    Negative Control: (ABIN7235032)

    Blocking Peptide: (ABIN7235032)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    0.2 mL double distilled water (DDW).

    Konzentration

    1 mg/mL

    Buffer

    PBS pH 7.4

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.

    Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).

  • Target

    CNR2 (Cannabinoid Receptor 2 (CNR2))

    Andere Bezeichnung

    CNR2

    Hintergrund

    CB2, CNR2,Cannabinoids have been used as pain relievers in Eastern medicine for many years.1 To date, two specific cannabinoid receptors have been identified: cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2).2 The cannabinoid receptors can be distinguished by their amino acid sequence, signaling mechanisms and tissue distribution.2 Both receptors belong to the G-protein coupled receptor superfamily and are coupled to Gi/0 G protein.2,3The CB2 receptor is highly expressed in cells of the immune system such as macrophages, lymphocytes natural killer cells and mast cells but has also been shown to be expressed, by both, in situ-hybridization and in immunohistochemistry, in spleen, thymus, and pancreas.1,2,4 CB2 expression in the brain is still much less characterized than that of CB1. Recently, it was demonstrated that CB2 is expressed in the brain and might have a role in controlling fundamental processes such as proliferation and survival of neural cells.5,6Overexpression of CB2 was reported in several cancers such as prostate, glioma and acute myeloid leukemias.6 In human astrocytoma a direct relationship between CB2 expression and tumor malignancy was demonstrated. Activation of CB2 in vivo by its agonist JWH-133, completely blocked cell growth. In C6 glioma, it was shown that activation of the CB2 by JWH-133 resulted in the internalization of only the CB2 and not CB1 leading to apoptosis of the cells. This may well be a new approach for the treatment of glioma.7

    Alternative names: Cannabinoid Receptor 2, CB2, CNR2

    Gen-ID

    57302

    NCBI Accession

    NM_001841

    UniProt

    Q9QZN9
Sie sind hier:
Chat with us!